SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S.
3 references·16 citing·41 second hop
Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. (2002)Lifetime Costs of Complications Resulting…Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) (2000)Cost effectiveness of an inte…Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)Economic Consequences of Diab…Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Model of Complications of NID…Estimated Lifetime Economic Burden of Type 1 Diabetes (2019)Estimated Lifetime Economic B…The Cost of Diabetes-Related Complications: Registry-Based Analysis of Days Absent from Work (2013)The Cost of Diabetes-Related …National Healthcare Disparities Report, 2012 (2013)National Healthcare Dispariti…Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México (2013)Health Disparities from Econo…The Economics of Diabetes Prevention (2011)The Economics of Diabetes Pre…Costos de la Diabetes en Ameŕica Latina: Evidencias del Caso Mexicano (2011)Costos de la Diabetes en Ameŕ…Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran (2011)Cost-of-Illness Analysis of T…Cost of diabetes care in out-patient clinics of Karachi, Pakistan (2007)Cost of diabetes care in out-…Pharmacoeconomic Analyses Using Discrete Event Simulation (2005)Pharmacoeconomic Analyses Usi…National Healthcare Disparities Report, 2005 (2005)National Healthcare Dispariti…Social and cultural barriers to diabetes prevention in Oklahoma American Indian women. (2004)Social and cultural barriers …Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Screening for Type 2 Diabetes…National Healthcare Disparities Report, 2004 (2004)National Healthcare Dispariti…Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada (2004)Economic evaluation of therap…Direct Health Care Costs of Diabetic Patients in Spain (2004)Direct Health Care Costs of D…National Healthcare Disparities Report (2003)National Healthcare Dispariti…Costs, effects and C/E‐ratios alongside a clinical trial (1994)The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in the U.S. in 2002 (2003)The cost of diabetes in Latin America and the Caribbean. (2003)Assessment of the direct medical costs of diabetes mellitus and its complications in the United Arab Emirates (2010)The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia: A Systematic Review (2017)Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study (2019)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults (2007)Screening Adults for Pre-Diabetes and Diabetes May Be Cost-Saving (2010)Simulation Modeling and Analysis. (1983)Discrete-Event System Simulation (1984)Markov Models in Medical Decision Making (1993)Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations? (2010)Overview of Parametric Survival Analysis for Health-Economic Applications (2013)Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report (2014)El coste de la diabetes tipo 2 en España. El estudio CODE-2 (2002)Cost-of-Illness Studies in Diabetes Mellitus (2004)Type 2 diabetes mellitus in China: a preventable economic burden. (2009)Costs, outcomes and challenges for diabetes care in Spain (2013)Economic Costs of Diabetes in the U.S. in 2007 (2008)Cost-of-illness studies of diabetes mellitus: A systematic review (2014)Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis (2015)Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review (2018)Rising Out-Of-Pocket Spending For Chronic Conditions: A Ten-Year Trend (2009)Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications (2013)Impact of Primary Care Patient Visits on Racial and Ethnic Disparities in Preventive Care in the United States (2007)Listening to Rural Hispanic Immigrants in the Midwest: A Community-Based Participatory Assessment of Major Barriers to Health Care Access and Use (2008)Suicide and Suicide Risk in Lesbian, Gay, Bisexual, and Transgender Populations: Review and Recommendations (2010)Hispanic Lesbians and Bisexual Women at Heightened Risk or Health Disparities (2011)2013 NCHS Urban-Rural Classification Scheme for Counties. (2012)The Health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding (2012)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Health Care Economic Analyses and Value-Based Medicine (2003)Revealing the cost of Type II diabetes in Europe (2002)A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) (2004)
this work references cited by second hop

References

  • 1998Economic Consequences of Diabetes Mellitus in the U.S. in 1997652 cited
  • 1997Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia333 cited
  • 2000Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)322 cited

Cited by

  • 2005Pharmacoeconomic Analyses Using Discrete Event Simulation191 cited
  • 2004Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis178 cited
  • 2004Direct Health Care Costs of Diabetic Patients in Spain147 cited
  • 2011Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran135 cited
  • 2007Cost of diabetes care in out-patient clinics of Karachi, Pakistan133 cited
  • 2019Estimated Lifetime Economic Burden of Type 1 Diabetes96 cited
  • 2005National Healthcare Disparities Report, 200570 cited
  • 2004Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada67 cited
  • 2011Costos de la Diabetes en Ameŕica Latina: Evidencias del Caso Mexicano65 cited
  • 2004National Healthcare Disparities Report, 200463 cited
  • 2011The Economics of Diabetes Prevention60 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2013The Cost of Diabetes-Related Complications: Registry-Based Analysis of Days Absent from Work58 cited
  • 2013Health Disparities from Economic Burden of Diabetes in Middle-income Countries: Evidence from México54 cited
  • 2013National Healthcare Disparities Report, 201248 cited
  • 2003National Healthcare Disparities Report38 cited
  • 2004Social and cultural barriers to diabetes prevention in Oklahoma American Indian women.35 cited